Eukaryotic translation initiation factor 2B (eIF2B) is a master regulator of protein synthesis under normal and stress conditions. Mutations in any of the five genes encoding its subunits lead to vanishing white matter (VWM) disease, a recessive genetic deadly illness caused by progressive loss of white matter in the brain. In this study we used fibroblasts, which are not involved in the disease, to demonstrate the involvement of eIF2B in mitochondrial function and abundance. Mass spectrometry of total proteome of mouse embryonic fibroblasts (MEFs) isolated from Eif2b5 R132H/R132H mice revealed unbalanced stoichiometry of proteins involved in oxidative phosphorylation and of mitochondrial translation machinery components, among others. Mutant MEFs exhibit 55% decrease in oxygen consumption rate per mtDNA content and 47% increase in mitochondrial abundance (p < 0.005), reflecting adaptation to energy requirements. A more robust eIF2B-associated oxidative respiration deficiency was found in mutant primary astrocytes, which exhibit > 3-fold lower ATPlinked respiration per cell despite a 2-fold increase in mtDNA content (p < 0.03). The 2-fold increase in basal and stimulated glycolysis in mutant astrocytes (p ≤ 0.03), but not in MEFs, demonstrates their higher energetic needs and further explicates their involvement in the disease. The data demonstrate the critical role of eIF2B in tight coordination of expression from nuclear and mitochondrial genomes and illuminates the importance of mitochondrial function in VWM pathology. Further dissection of the signaling network associated with eIF2B function will help generating therapeutic strategies for VWM disease and possibly other neurodegenerative disorders.
Eukaryotic translation initiation factor 2B (eIF2B), a 5-subunit complex, is a major regulator of protein synthesis under normal and stress conditions (Pavitt 2005) . In each round of translation initiation step, GTP-bound eIF2 binds Met-tRNA i Met and delivers it to the 40S ribosomal subunit. AUG recognition triggers GTP hydrolysis and release of eIF2 . GDP, which in turn undergoes recycling to eIF2
. GTP by eIF2B, the guanine nucleotide exchange factor of eIF2. By controlling the level of eIF2
. GTP .
Met-tRNA i Met ternary complexes, eIF2B activity governs the rate of global translation. The responsiveness of its enzymatic activity to the ever-changing cellular milieu is essential for cellular homeostasis.
Vanishing white matter (VWM) disease, also termed Childhood Ataxia with CNS Hypomyelination (OMIM#306896), is a recessive neurodegenerative disease caused by mutations in any of the five genes encoding the eIF2B subunits (Leegwater et al. 2001) . The disease is characterized by progressive loss of white matter in both hemispheres of the brain. The consequent axonal degeneration results in progressive impairments of neurologic functions, leading to complete paralysis and early death. An important feature of the disease is the deterioration of clinical symptoms upon exposure to physiological and environmental stressors. Most VWM mutations decrease the enzymatic activity of eIF2B. While mild mutations involve only brain pathology, severe mutations in rare congenital VWM patients involve damage to additional organs (Fogli and BoespflugTanguy 2006; Bugiani et al. 2010; Elroy-Stein and Schiffmann 2015) . Hence, brain white matter formation and maintenance is more sensitive to impairments of translation regulation compared to other tissues.
To study VWM disease, we have previously generated the Eif2b5 R132H/R132H mouse model (Geva et al. 2010) . The mutant homozygous mice exhibit only~20% decrease in brain eIF2B guanine nucleotide exchange factor activity, but this is sufficient to cause mild impairment of motor functions with involvement of white matter deficits. Eif2b5 R132H/R132H mice provided fundamental insights related to the etiology of the disease, including delayed postnatal brain development, abnormal glial cell abundance, increased abundance of demyelinated axons and axons ensheathed with split and damaged myelin, failure to overcome cuprizone-induced demyelination, poor astrogliosis, and impaired cerebral inflammatory response upon insults (Geva et al. 2010; Cabilly et al. 2012) . At the molecular 'omics' level, we found unique time point-specific transcriptome signatures reflecting delayed waves of gene expression, as well as unbalanced expression of unfolded protein response-related genes at early postnatal stages (Marom et al. 2011) . In a recent proteomics study focusing on remyelination in adult mice brains in response to cuprizone-induced demyelination, we found proteome signatures reflecting dysregulation of mitochondrial functions (Gat-Viks et al. 2015) . As postmortem brains of several VWM patients contain oligodendrocytes with 'foamy' cytoplasm as a result of increased number of abnormal mitochondrial membranes (Wong et al. 2000) , we aimed to find a biochemical link between eIF2B mutations and mitochondrial function.
Although mitochondrial dysfunction is a secondary phenomenon in many neurodegenerative diseases including other leukodystrophies, we hypothesized that the case of VWM disease is exceptional in this respect. Unlike other diseases, VWM is driven by mutations in eIF2B, a master regulator of cytoplasmic mRNA translation. While only 37 genes (encoding rRNA, tRNA and 13 proteins) comprise the mitochondrial genome,~1000 nuclear genes encode the rest of the mitochondrial proteins, with hundreds of additional nuclear genes thought to play important roles in mitochondrial functions (Vafai and Mootha 2012; Calvo et al. 2016) . The expression from both genomes is intensely regulated to adjust mitochondrial mass and performance to cellular energetic requirements (Taanman 1999; Jacobs and Turnbull 2005; Quiros et al. 2016 ). Owing to the importance of tightly controlled cytoplasmic translation, we hypothesized that mitochondrial impairment may be a primary deficit in VWM disease. Given that Eif2b5 R132H/R132H mice exhibit mild neurological symptoms, we reasoned that they are an ideal choice for this study to rule out a secondary phenomenon of mitochondrial malfunction caused by a general cellular dysfunction. Moreover, as fibroblasts do not exhibit any clinical symptoms in VWM patients, we reasoned that demonstrating a mitochondrial phenotype in this cell type would serve as an ample proof of concept.
Here, via an in vitro mechanistic study using mouse embryonic fibroblasts (MEFs) isolated from Eif2b5 R132H/ R132H (Mut) and wild-type (WT) control mice we show that the mutation leads to: (i) increased mitochondrial abundance; (ii) increased steady-state levels of mitochondrial proteins; (iii) compromised mitochondrial translation and consequent decreased synthesis of mitochondrial-encoded subunits of the electron transfer chain (ETC.) complexes; and (vi) decreased oxidative respiration. Furthermore, we found increased mitochondria abundance in brains and primary astrocytes harboring the mutation; and impaired oxidative respiration in Mut primary astrocytes. Importantly, whereas the mutation elicits a mild effect on MEFs, mitochondrial dysfunction is more robust in astrocytes.
Methods
Mice, primary MEF, and astrocytes Wild-type (WT; C57BL strain) and Eif2b5 R132H/R132H (Mut; mutant) mice of both sexes were bred and housed in Tel Aviv University animal facility with 14/10 h light/dark cycle in groups of four animals per cage in individually ventilated cages (Lab Products Inc., Seaford, DE, USA) supplemented with autoclaved wood chips. Animals were fed with autoclaved rodent pellet (Koffolk 19-510; Koffolk Ltd, Petach Tikva, Israel) and sterile water ad libitum. All experimental procedures were approved by the Tel Aviv University Animal Care Committee according to national guidelines (permits #L-15-037 and #04-12-27). Breeding and genotyping were performed as previously described (Geva et al. 2010) . Each generation was established by back cross of homozygous Mut with WT C57BL/6J (Harlan Labs, Jerusalem, Israel) to prevent genetic drift. MEFs were isolated from E14 embryos as previously described (Xu 2005) . All experiments were performed using freshly thawed MEFs that were grown to passage 3 in Dulbeco modified Eagel's medium (DMEM), high glucose (#01-055-1; Biological Industries, Beit Haemek, Israel) supplemented with 10% Fetal Bovine Serum, 100-U/mL penicillin, 0.1-mg/mL streptomycin, 2-mM L-glutamine, and MEM non-essential amino acids and 24 h later were plated for experiment. The above medium was used for InCell and ATP/ADP ratio measurements, whereas DMEM (#01-057-1A; Biological Industries) supplemented with 10-mM glucose and all the above-mentioned supplements were used for all the rest of the experiments.
Primary astrocytes were isolated from P0 to P2 brains following papain dissociation to single-cell suspension using MACS Neural Tissue Dissociation kit (#130-092-628; Miltenyi Biotec, Bergisch Gladbach, Germany) and Gentle-MACS dissociator according to the manufacturer's protocol. Astrocytes were positively selected using anti-ACSA2 MicroBead Kit (#130-097-678; Miltenyi Biotec), seeded at a density of 23 000 cells per 6-cm plate in astrocyte medium (#1801; ScienCell Research Labs, Carlsbad, CA, USA), split to passage 2, frozen, and stored in liquid nitrogen. All experiments were performed using freshly thawed primary astrocytes at passage 3, and grown in astrocyte medium (#1801; ScienCell Research Labs).
Image-based high content analysis of single cells MEFs were seeded on 1% gelatin-coated 96-well plate at a density of 5000 cells per well. Twenty-four hours postplating the medium was changed as described above and 24 h later were stained by addition of 2-lg/mL Hoechst 33258 (#861405; Sigma-Aldrich, Rehovot, Israel), 1-lM DCF-DA (#35845; Sigma-Aldrich), 100-nM MitoTracker 
Flow cytometry
Cell size Single-cell suspension in phosphate-buffered saline was analyzed by flow cytometry using FACSort cytometer (BD Biosciences, San Jose, CA, USA).
Cell cycle
Cell cycle was analyzed as previously described (Sivan et al. 2011) .
TMRE staining
Tetra-Methyl-Rhodamine-Ethyl esterperchlorate (TMRE) staining 3.3 9 10 5 Primary WT and Mut MEFs were seeded at a density of 3.3 9 10 5 cells per 6-cm plate for 24 h followed by staining with 200-nM TMRE (Abcam, Cambridge, UK) for 30 min. For negative and positive controls 1.5-lM carbonyl cyanide 4-(trifluoro-methoxy) phenylhydrazone (FCCP) or 1.0-lM oligomycing, respectively, was included 2 min prior to TMRE. Cell were removed by trypsinyzation, washed and resuspended in phosphatebuffered saline. Approximately eight thousand cells were analyzed by SONY SH800 cell sorter (Sony Biotech Inc., San Jose, CA, USA) and FlowJo software (FLOWJO, LLC, Ashland, Oregon, USA).
Oxygen consumption and extracellular acidification Oxygen consumption extracellular acidification was measured in primary MEFs and astrocytes using a XF96 Extracellular Flux Analyzer (Seahorse Bioscience, Billerica, MA, USA) as described (Invernizzi et al. 2012) . Primary MEFs or astrocytes were seeded in a XF96-well cell culture mircoplate at a density of 5000 cells/well and incubated for 24 h or 72 h, respectively, in 80 lL of MEF medium or astrocytes medium (#1801; Sciencell Research Labs), at 37°C in 5% CO 2 atmosphere prior to analysis. The Mito Stress and Glyco Stress Test Kits (Agilent Technologies, Santa Clara, CA, USA) were used to measure oxygen consumption rate (OCR) and extracellular acidification rate (ECAR), respectively. For OCR: the medium was replaced with 180 lL of bicarbonate-free DMEM (Seahorse medium #102353) supplemented with 2-mM L-glutamine, 10-mM Glucose, and 1-mM sodium pyruvate, pre-warmed at 37°C, and tittered to pH 7.4 AE 0.01. Cells were pre-incubated for 1 h without CO 2 before starting the assay procedure. OCR, leaking respiration (LR), maximal capacity respiration, and nonmitochondrial respiration were determined as recommended by the supplier. We used oligomycin (1 lM), (FCCP; 1 lM for MEFs, 1.5 lM for astrocytes), antimycin A (0.5 lM), and rotenone (0.5 lM). The uncoupler concentration has been optimized for both MEFs and astrocytes to insure that maximal respiration capacity is revealed. For ECAR: as above, but the assay medium did not contain glucose and sodium pyruvate. Cells were pre-incubated for 1 h without CO 2 before starting the assay procedure. We used sequential addition of glucose (10 mM), oligomycin A (1 lM), and 2-deoxy-D-glucose (2-DG; 50 mM). For both OCR and ECAR, the data were normalized to biomass, obtained Crystal Violet staining as previously described (Heiss et al. 2014) . When relevant, the data were also normalized for mtDNA content.
Drug sensitivity assay
MEFs were seeded on 1% gelatin-coated 96-well plate at a density of 1000 cells per well. Twenty-four hours postplating the medium was changed to MEF medium containing Chloramphenicol or Antimycin A at increasing concentrations for 72 h. The cells were fixed with 4% paraformaldehyde, stained with 2 lg/mL Hoechst 33258 (in HBSS for 2 h at 25°C washed with HBSS, and subjected to fluorescent acquisition using IN Cell Analyzer 2000 (GE Healthcare). Cell count was determined using IN Cell Developer Toolbox 1.9.1 software (GE Healthcare).
Statistics
In all comparisons, Student's t-test was performed using ≥ 3 independent biological repeats for each genotype group (we did not apply any methodological selection of sample size). Fisher's combined probability test was used when indicated.
Data accessibility
Raw MS data are deposited in PRIDE Archive, project number PXD005854.
Refer to the online supplementary material (Appendix S1) for methods of mtDNA quantification, ETC I and IV activities, ATP/ADP ratio, Cytoplasmic and mitochondrial Protein Synthesis, MTCO1 and SDHB protein and mRNA levels, Isolation of Brain Mitochondria, Proteome Analysis of primary MEFs (Mass Spectrometry and Data Analysis).
Results

Increased mitochondrial abundance
We first examined mitochondrial abundance in primary MEFs isolated from Eif2b5 R132H/R132H (Mut) and WT mice using MitoTracker DeepRed FM. Image-based single-cell analysis showed increased signal in Mut MEFs, with 1.4-fold higher average compared to WT (p = 0.02). A threshold set as the median integrated intensity of WT revealed that 75% of Mut MEFs were above this threshold, indicating their higher mitochondrial content (Fig. 1a) . Cell size analysis measured by flow cytometry confirmed that Mut MEFs did not exhibit a significant cell volume abnormality (Fig. 1b) .
As reactive oxygen species (ROS) are by-products of mitochondrial oxidative respiration, we used DCF-DA, a fluorogenic dye specific for ROS, and found that 79% of Mut MEFs are 'High ROS'-containing cells, compared to 50% of WT, with the average intensity being 1.45-fold higher in Mut MEFs (p = 0.002; Fig. 1c ), in agreement with their increased mitochondrial mass. qPCR quantification of DNA demonstrates a 1.47-fold increase (p = 8E-06) in the ratio of mitochondrial 12S rRNA to nuclear 18S rRNA genes (Fig. 1d) . Taken together, the data indicate that the Eif2b5 R132H mutation is associated with increased mitochondrial content.
To obtain an initial indication regarding mitochondrial function, we used additional probes. First, the cells were stained with JC-1 which indicates high and low membrane potential by red and green emission, respectively. Setting the median integrated intensity of the red or green JC1 signals of WT MEFs as thresholds revealed that 61% and 63% of Mut MEFs, respectively, were above the threshold (Fig. 2a left and right panels) and that the green/red ratio was similar in both genotypes. This observation indicates that the increased mitochondrial mass in Mut MEFs contains a similar proportion of polarized and depolarized mitochondria. We next stained the cells with TMRE, a positively charged dye that accumulates in active mitochondria, and used ATP-synthase inhibitor (oligomycin) and an uncoupler (FCCP) as a positive and negative control, respectively. The dynamic range of TMRE staining was similar for both cell types. However, the mean basal TMRE fluorescence per cell was 13% lower in Mut than WT MEFs (p = 0.05, Fig. 2b ), despite the increased mitochondrial content in Mut MEFs (Fig. 1) . Setting the intensity threshold to fit only the upper 25%, 10%, or 5% top-fluorescent WT cells revealed that only 22%, 5.8%, and 1.3% of the Mut cells, respectively, were above these thresholds (Fig. 2b) . Together, the data support the notion of compromised mitochondrial membrane potential in Mut MEFs.
Impaired mitochondrial oxidative phosphorylation
To further evaluate mitochondrial performance, we measured oxygen consumption rate (OCR) and normalized it to mitochondrial content, as defined by mitochondrial DNA (mtDNA) quantification (Fig. 1d) . Oxygen consumption per mtDNA content in Mut MEFs was 50-55% (p < 0.005) of that in WT MEFs for basal, maximal, and ATP-linked respiration, indicating oxidative phosphorylation deficiency (Fig. 3a, right) . The similar cell cycle of both genotypes ruled out differential demands for ATP driven by variance in their proliferation rates (Fig. 3b) . Measurements of extra cellular acidification rate (ECAR) showed that in Mut MEFs the basal, stimulated and spare glycolysis was similar to WT (Fig. 3c) , suggesting that for compensation purposes the increased mitochondrial content is sufficient, as indicated by the non-significant change in OCR per cell (Fig. 3a, left) . We then tested the activities of two ETC complexes essential for mitochondrial oxidative phosphorylation. As expected, activities of NADH dehydrogenase (complex I) and cytochrome C oxidase (complex IV) per mtDNA content were lower by 30% and 40%, respectively, in Mut compared to WT MEFs (p ≤ 0.002, Fig. 3d and e) . However, the activities of both ETC complexes per cell were similar in both genotypes, further demonstrating that the increased mitochondrial content per cell in Mut MEFs is a result of a compensatory feedback to increase ATP production by oxidative phosphorylation (oxphos). The subnormal relative energetic status of Mut MEFs as demonstrated by their lower relative ATP/ADP ratio (Fig. 3f) indicates that the compensation is not complete; nonetheless it probably meets the needs of MEFs grown in culture.
Decreased synthesis of mitochondria-encoded oxidative phosphorylation proteins About 90% of the energy used by mammalian cells is generated via oxphos by the four ETC complexes (I-IV) coupled to ATP-synthase (complex V). Altogether, they are composed of 89 proteins, 13 of which are encoded by the mitochondrial genome and translated inside the organelle. Complex II is the only multi-protein complex involved in electron transport and oxidative phosphorylation that is encoded exclusively in the nucleus. Deficient oxphos can result from abnormal stoichiometry between the components constituting the ETC and ATP-synthase complexes. To test this possibility, we undertook an unbiased mass spectrometrybased proteomic approach to compare the steady-state level of total cell proteins. We used SILAC-labeled immortalized WT MEFs as a 'spike-in' reference standard to obtain accurate relative quantification of the experimental samples. Total of 5400 proteins were detected, including 425 mitochondria resident proteins, 71 of which are part of the oxphos complexes (Table S1 ). Figure 4a shows that over the entire quantified proteome (5476 proteins), the average fold change (FC) of Mut compared to WT is slightly low. A similar trend was observed for the 5051 non-mitochondrial proteins group. In contrast, the average FC of the 425 mitochondrial proteins group was significantly higher compared to the group of nonmitochondrial proteins (p < 4E-04, Fig. 4a ), in agreement with the increased mitochondria content in Mut cells. Interestingly, we found large variation in the FC of oxphos complexes proteins. To identify the underlying cause of this variation, we examined the FC of the individual oxphos proteins, given that 76 of them are encoded by nuclear DNA and only 13 are encoded by the mitochondrial genome (Taanman 1999) . Interestingly, the average FC of the group containing the four detected mitochondrial-encoded oxphos proteins (mt-Co1, mt-Co2, mt-Co3, and mt-Atp8, Table S1 ) was significantly lower compared to the group containing the 67 detected nuclear-encoded oxphos proteins (p = 1.4E-06, Fig. 4b ). Further inspection of these subgroups within specific oxphos complexes, revealed significant reduced abundance of the three detected mitochondrial-encoded proteins within complex IV, compared to their nuclearencoded partners, in Mut MEFs (p = 0.003, Fig. 4c ). Importantly, while the FC of the nuclear-encoded oxphos proteins revealed a spectrum of positive and negative values, the statistically significant decrease in the FC of the four detected mitochondrial-encoded ones (p = 0.057, Fisher's combined probability test), further emphasizes the implication of their reduced quantity in Mut MEFs. To validate the mass spectrometry data, we chose to quantify MTCO1, the mitochondria-encoded catalytic subunit of complex IV, and SDHB, the nuclear-encoded subunit of complex II, as representatives. In accordance with the proteomics results, Mut MEFs expressed a lower level of MTCO1, and a similar level of SDHB, yielding a~30% lower MTCO1-to-SDHB ratio in Mut compared to WT MEFs (p = 0.01, Fig. 4d ). Chloramphenicol, a specific inhibitor of mitochondrial translation, eliminated the expression of MTCO1 but not of SDHB (Fig. 4d) , confirming that mt-Co1 mRNA is translated in the mitochondrial compartment. The significantly higher level of mt-Co1 mRNA in Mut compared to WT MEFs (p = 0.003, Fig. 4e ) supports the notion of its impaired translation. Together, the observations support the concept of a negative effect of the mutation in Eif2b5 gene on the efficiency of mitochondrial protein synthesis.
Compromised mitochondrial translation
To test the effect of the Eif2b5 mutation on global cytoplasmic and mitochondrial protein synthesis, we measured [ 35 S]-Met/Cys incorporation. Similar global translation was observed in the cytoplasm of Mut and WT MEFs (Fig. 5a) , consistent with the SILAC data in terms of global protein synthesis (Fig. 4a) . Analysis of mitochondrial translation using emetine, a specific inhibitor of cytoplasmic translation, showed lack of significant difference between Mut and WT MEFs when normalized to cells number (Fig. 5b, left) . However, mitochondrial translation per mtDNA content was~35% lower in Mut relative to WT MEFs ( Fig. 5b, right ; p = 2.4E-10). To evaluate possible reasons for impaired mitochondrial translation we re- MEFs were cultured in the presence or absence of 10-lg/mL chloramphenicol (CAM) prior to immunoblot analysis using antibodies specific to mitochondrial-encoded MTCO1 (complex IV) and nuclear-encoded SDHB (complex II). Antibody specific for b-tubulin was used for loading control. Shown is a representative immunoblot and quantification of MTCO1/SDHB ratio of three independent experiments AE SEM. *p = 0.01. (e) RT-qPCR of mt-Co1, Sdhb, and Gapdh mRNA using total RNA extracted from WT and Mut MEFs. Shown is relative quantity (RQ) of mt-Co1/Gapdh and Sdhb/Gapdh ratios following ΔΔC T analysis of five independent experiments AE SEM. *p = 0.003. assessed the above-described SILAC data which revealed significantly higher average FCs of protein groups containing five mitochondrial translation factors ( Fig. 5c ; Fisher's combined p = 2.6E-05) and 11 mitochondrial aminoacyltRNA synthetases ( Fig. 5d ; Fisher's combined p = 2E-07) in Mut compared to WT, in agreement with the increased mitochondrial content in Mut MEFs. However, FC abundance of 69 mitochondrial ribosomal proteins (MRP) reveals a spectrum of positive and negative values (Fig. 5e) . The significant increased abundance of MRPL21, 37, 39, 44 by 10-16% (p < 0.05) and decreased abundance of MRPL16 by 18% (p < 0.03) in Mut MEFs indicates abnormal stoichiometry within the large 39S mitochondrial ribosome subunit, which may compromise the efficiency of mitochondrial translation.
To test if inhibition of mitochondrial translation leads to increased mitochondrial biogenesis, mtDNA content was analyzed following 24 h incubation with 10-lg/mL chloramphenicol. As expected, chloramphenicol treatment of WT MEFs caused an increase of~30% (p < 8E-05, Fig. 6a ) in mtDNA amount, reaching a level similar to that of untreated Mut MEFs. In contrast, chloramphenicol treatment of Mut MEFs did not lead to any further increase in mtDNA, suggesting that in Mut cells the compensation has reached its maximal capacity. In agreement with this idea is the increased sensitivity of Mut cells specifically to chloramphenicol but not to antimycin A, an ETC complex III inhibitor, as quantified by survival rates (p < 0.03, Fig. 6b  and c) . This observation further supports the notion that increased mitochondrial biogenesis in Mut MEFs is a compensatory response. The ability of chloramphenicol to mimic the effect of the eIF2B5-R132H mutation in WT MEFs suggests a novel translation-dependent role for eIF2B5 in VWM pathology involving mitochondrial function.
Malfunction and increased abundance of mitochondria in brain and primary astrocytes
To test the relevance of our findings to the brain, we first examined mitochondrial abundance. qPCR quantification using brain extracts from P21 mice demonstrated an increase of~30% in mtDNA-to-nucDNA ratio in Mut compared to WT brains (p = 1.3E-07; Fig. 7a ) and~20% increase in the amount of mitochondria obtained per brain tissue weight (p = 0.003; Fig. 7b) , consistent with the high mitochondrial content in Mut MEFs (Fig. 1) . Quantification of MTCO1 and SDHB proteins in isolated brain mitochondria showed a~10% decrease in MTCO1/SDHB protein ratio in Mut compared to WT (p = 0.006; Fig. 7c ). Since astrocytes are involved in VWM disease (Dietrich et al. 2005 ) (Bugiani et al. 2011) (Cabilly et al. 2012) (Bugiani et al. 2013) (Dooves et al. 2016) , we further tested primary astrocytes isolated from brains of newborn Mut and WT mice and intriguingly found a more robust abnormal mitochondrial phenotype. Although mtDNA-to-nucDNA ratio was~2-fold higher in Mut astrocytes (p = 0.025; Fig. 7d ), their basal respiration was > 2-fold lower compared to WT, as quantified by oxygen consumption (p < 0.001; Fig. 7e ). Moreover, while in WT astrocytes the maximal respiration was~2-fold higher than the basal respiration, in Mut astrocytes both rates were similar. Furthermore, ATP-linked respiration in Mut was > 3-fold lower than that of WT (p < 0.001; Fig. 7e) . Notably, the Fig. 6 Mut mouse embryonic fibroblasts (MEFs) are more sensitive to CAM and cannot further increase their mitochondrial abundance. (a) Primary WT and Mut MEFs were cultured in the presence or absence of 10 lg/mL CAM for 24 h followed by quantification of mtDNA as detailed in Fig. 1(a) . Shown is average relative quantity (RQ) of 3-7 independent experiments AE SEM. *p < 8E-05. negative effect of the Eif2B5 mutation on oxphos is more substantial in astrocytes compared to MEFs (compare Figs 3a to 7e). Specifically, while a~1.5-fold increase in mitochondrial abundance in MEFs (Fig. 1d) is sufficient for an effective oxphos compensation (OCR per mitochondria is low but OCR per cell is normal; Fig. 3a) , astrocytes fail to reach effective oxphos compensation (OCR per cell is dramatically low; Fig. 7e ), even following a~2-fold increase in mitochondrial content (Fig. 7d) . The similar cell cycle of WT and Mut astrocytes rules out differential demands for ATP driven by variance in proliferation rates (Fig. 7f) . The > 2-fold increase in basal and stimulated glycolysis in Mut compared to WT astrocytes (p ≤ 0.03; Fig. 7g ) demonstrates the high energetic requirements of astrocytes compared to MEFs (Fig. 3) , hence their enhanced sensitivity to impaired mitochondrial oxidative respiration.
Discussion
This study provides evidence that even a mild mutation in eIF2B, leading merely to a~20% decrease in its enzymatic activity, is associated with mitochondrial malfunction caused by defective oxphos and with increased mitochondrial biogenesis compensating for energetic needs. These findings are in line with our previous unbiased 'omics' studies. First, P21 Mut mice brains demonstrate transcriptome pattern (Marom et al. 2011) similar to the 'transcriptional signature' obtained from mitochondrial dysfunction cases caused by genetic mutations, lack of membrane potential, oxygen depletion, or decreased electron flow (Cortopassi et al. 2006) . Second, our proteome study clearly demonstrates the abnormal levels of oxphos proteins in the brains of Mut mice, along with their abortive attempt to recover from cuprizone-induced demyelination (Gat-Viks et al. 2015) . Together, the data indicate that oxidative phosphorylation impairment is a central feature of eIF2B-leukodystrophy.
eIF2B and mitochondrial biology Hypoactive eIF2B renders cells hypersensitive to ER-stress (Kantor et al. 2005 (Kantor et al. , 2008 and indeed VWM pathology involves a defective ER-stress response (van der Voorn et al. 2005; van Kollenburg et al. 2006) . However, in light of this study, it is not clear if the enhanced ER-stress state or the defective mitochondrial translation is the primary event. ERstress can lead to mitochondrial unfolded protein response via the physiological and mechanistic connection between these two compartments (Giorgi et al. 2009 ), whereas mitochondrial defects could generate ER-stress by decreasing correct protein folding in the ER as a result of depleted ATP levels (Ryan and Hoogenraad 2007) . The tight communication between cytoplasmic and mitochondrial translation machineries is further illustrated by the effect of inhibited mitochondrial translation on phosphorylation of the alpha subunit of eIF2, a cytoplasmic translation factor. This is a central event of integrated stress response leading to inhibition of cytoplasmic translation via inhibition of eIF2B activity. Concordantly, the outcome of mitochondrial bioenergetics defect in oligodendrocytes is a PERK-dependent rescue signaling pathway (Silva et al. 2009 ). Regardless of the cause-and-effect relationships between ER and mitochondria in VWM disease, this study clearly illuminates eIF2B, a master translation initiation factor, as a fine-tuner of integrated cellular protein synthesis as a result of its role as a coordinator of cytoplasmic and mitochondrial translation. Since the proper function of eIF2B, a multi-component complex, is sensitive to tight regulation of the co-stoichiometric expression of its subunits (Wortham et al. 2016) , a genetic rescue experiment by over-expressing the WT eIF2B5 subunit is not an option. However, in view of the fact that the mouse model was generated by homologous recombination into the Eif2b5 gene locus of a fragment containing the desired point mutation (Geva et al. 2010) , offtarget genetic effects are not expected. Moreover, the Eif2b5 R132H/R132H strain is continuously maintained by back crosses to WT C57BL/6J mice to prevent genetic drifts. It is tempting to speculate that the observed abnormal stoichiometry of the mitochondrial translation apparatus components in eIF2B-mutant cells is caused by the faulty regulation of their own translation in the cytoplasm, leading to the negative effect on translation efficiency within the mitochondria. Further research is required to unravel the involved cellular circuits affected by eIF2B partial loss of function, which remain largely speculative at this point.
Mitochondrial dysfunction and CNS white matter
Oligodendroglial precursor cells grow into immature oligodendrocytes, and finally into mature, myelin-producing oligodendrocytes. The amplification of mtDNA and transcripts during oligodendroglial differentiation in vitro, and the selective vulnerability of differentiating oligodendroglia to inhibitors of mitochondrial function (Schoenfeld et al. (a) qPCR analysis of mitochondrial 12S rRNA and nuclear 18S rRNA genes in whole cerebrum of P21 WT (six females and two males) and Mut (eight females and one male) mice. Shown is average relative quantity (RQ) normalized to WT AE SEM. *p = 1.37E-7. (b) Mitochondria were isolated from cerebrums of five P21 WT and Mut female mice followed by total protein quantification for yield assessment. Shown is average yield per tissue weight of five independent experiments normalized to WT AE SEM. *p = 0.003. (c) MTCO1 and SDHB protein levels in mitochondria isolated from cerebrums of P21 WT and Mut female mice. Shown are a representative immunoblot (left) and quantification of MTCO1/ SDHB ratio AE SEM of four independent experiments (right). *p = 0.006. (d) qPCR analysis of mitochondrial 12S rRNA and nuclear 18S rRNA genes in primary culture of astrocytes isolated from cerebrums of newborn WT and Mut mice. Shown is average relative quantity (RQ) of three independent experiments normalized to WT AE SEM. *p = 0.025. (e) Oxygen consumption rate (OCR) in WT and Mut primary astrocytes shown by pmol of oxygen consumed per minute for basal, maximal, and ATP-linked respiration, normalized to biomass, as detailed in Methods. Bars represent the mean values AE SEM of 15 replicates in a representative experiment of three independent experiments. *p < 0.001. (f) Cell cycle of WT (grey) and Mut (black) mouse embryonic fibroblasts (MEFs), as detailed in Fig. 3(b) . (g) Extra-cellular acidification rate (ECAR) shown as mpH per minute per biomass for basal, stimulated, and spare glycolysis of WT and Mut MEFs, as detailed in Methods. Bars represent average AE SEM of 10 replicates in a representative experiment of three independent experiments. *p ≤ 0.03. 2010), suggests strong dependence of the oligodendroglial differentiation program on ATP availability. The ATP requirement for myelin sheath formation in vivo (Bizzozero et al. 1999) , and the impaired differentiation of neural stem cells to neurons and oligodendrocytes as a result of genetic impairment of mitochondrial function (Diaz-Castro et al. 2015) , further support this impression. Moreover, the negative impact of mitochondrial deficiency on lipid biogenesis, vesicular secretion, and expression of oligodendrocyte-specific genes is consistent with demyelination as a common pathophysiological feature of mitochondrial disorders (Morato et al. 2014) . The significant increase in the numbers of pre-myelinating oligodendrocyte progenitors in the brains of VWM patients (Bugiani et al. 2011 (Bugiani et al. , 2013 ) is in agreement with the possible role of mitochondrial dysfunction in the differentiation of oligodendroglial precursor cells in the pathology of the disease. In addition to genetic faults within the mitochondrial genome which obviously result in diseases associated with oxidative respiration defects (Rotig 2011) , oxphos deficiencies represent a heterogeneous group of diseases caused by genetic defects in numerous nuclearencoded genes (www.mitomap.org) (Kohda et al. 2016) . Among these are genes encoding several mitochondrial translation machinery components such as aminoacyl-tRNA synthetases, ribosomal proteins, and mitochondrial translation factors. This study adds eIF2B, the 5-subunit nuclearencoded cytoplasmic translation initiation factor, to the list.
This study demonstrates the high sensitivity of astrocytes to oxphos dysfunction emphasized by the negative effect of eIF2B partial loss of function on coordination of cytoplasmic and mitochondrial translation programs. The increased vulnerability of astrocytes supports previous studies suggesting a critical role for astrocytes in the pathophysiology of VWM (Dietrich et al. 2005) (Bugiani et al. 2011) (Cabilly et al. 2012) (Bugiani et al. 2013) (Dooves et al. 2016) , and provides an additional explanation for their malfunction in the brain of VWM patients. The increased mitochondrial content and elevated glycolysis as a result of the mutation in Eif2B5 gene is consistent with their adaptation attempts to meet their essential energy requirements. Further elucidation of the signaling network associated with eIF2B function will help in developing therapeutic strategies for VWM disease, and possibly other neurodegenerative disorders.
